POMC and pituitary tumor: A case series of four patients with aggressive ACTH producing pituitary tumors were treated with CAP-TMZ; two out of four patients demonstrated complete regression of the disease, one patient had a 75% regression, and one had an ongoing stable disease for 4.5 years at the time of the report (9).